Truvian Health (“Truvian”) today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance (K251058) for TruVerus™, the industry’s first multimodal blood testing benchtop instrument

CMS has finalized a 2.6% increase in outpatient payment rates for hospitals, effective in 2026, amid ongoing financial pressures and industry concerns.

Asian Hospital and Medical Center and Takeda Healthcare Philippines have signed a major collaboration to deliver broader patient access to advanced medicines for rare and complex conditions, marking a significant step toward sustainable and equitable care delivery for Filipino patients.

The European Commission's proposed 'AI Act Pause' and a €650 million venture fund are sparking major opportunities and competitive shifts in Europe’s MedTech and hospital sectors.

CMS has finalized substantial 2026 Medicare reimbursement increases for Nyxoah’s Genio hypoglossal nerve stimulation implants, strengthening hospital and ASC economics for sleep apnea care.

CMS sets new reimbursement rates for Caristo's AI-powered CaRi-Plaque coronary plaque analysis, enabling broader adoption in hospitals and imaging centers.

Takeda Healthcare Philippines and Asian Hospital signed a major agreement to boost sustainable access to innovative rare disease treatments for Filipino patients.

Jersey’s new Overdale Acute Hospital project reached three major construction milestones as part of the island’s most ambitious healthcare infrastructure upgrade, with implications for hospital facilities management and clinical capabilities.

Asian Hospital and Takeda Healthcare Philippines have launched a strategic partnership to enhance equitable access to innovative medicines for rare disease patients.

EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) announces new safety signals for hospital pharmaceuticals, prompting immediate review and operational updates in European hospital pharmacies.